Aura Biosciences (AURA) Other Operating Expenses (2021 - 2022)

Aura Biosciences (AURA) posted Other Operating Expenses of -$313000.0 for Q3 2022, down 6160.0% on a QoQ basis from -$5000.0 in Q1 2022.

Aura Biosciences (AURA) Other Operating Expenses (2021 - 2022) Analysis & Trends

Aura Biosciences' Other Operating Expenses history runs 2 years deep, the most recent figure standing at -$313000.0 for Q3 2022.

Quarterly Other Operating Expenses changed N/A year-over-year to -$313000.0 in Q3 2022, while the trailing twelve-month figure through Jun 2023 was -$313000.0 (down 6160.0% YoY) and the FY2023 annual result came in at $208000.0, up 165.41% from the prior year.
Other Operating Expenses was -$313000.0 for Q3 2022 at Aura Biosciences, down from -$5000.0 in the prior quarter.
Across five years, Other Operating Expenses topped out at -$3000.0 in Q1 2021 and bottomed at -$313000.0 in Q3 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Oculis Holding AG	66,621.14 Bn	66,620.85 Bn	-
2	Nanobiotix	1,915.18 Bn	1,915.11 Bn	-
3	Akari Therapeutics	1,014.18 Bn	1,014.18 Bn	-
4	BeOne Medicines	471.27 Bn	466.48 Bn	1.35 Bn
5	Vertex Pharmaceuticals	121.81 Bn	114.57 Bn	2.59 Bn
6	Regeneron Pharmaceuticals	69.58 Bn	60.82 Bn	3.31 Bn
7	Belite Bio	62.72 Bn	62.72 Bn	-
8	Argenx Se	55.51 Bn	50.33 Bn	1.41 Bn
9	Revolution Medicines	37.35 Bn	37.35 Bn	-
10	Aura Biosciences	484.61 Mn	399.82 Mn	-

Download Data